News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|June 5, 2024

Evolving Commercialization and Distribution Models for PDTs

The panel discusses the challenges of delivering prescription digital therapeutics (PDTs) to patients, challenges caused by PDTs being considered behavioral health benefits, pharmacy benefits, medical benefits, and durable medical equipment benefits.

Episodes in this series

Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"

EP. 1 Differentiating PDTs from Wellness Apps and Evaluating Efficacy

Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"

EP. 2 Payer Needs and Strategies for Evaluating and Covering PDTs

A panel of 4 experts on PDTs

EP. 3 Payers Review Process and Effective Strategies for PDT Coverage

A panel of 4 experts on PDTs

EP. 4 Stakeholder Involvement and Evidence Requirements for PDT Coverage Decisions

Video 5 - "Dawn of the Age of Adopting PDTs"

EP. 5 Dawn of the Age of Adopting PDTs

Video 6 -"Identifying the Most Impactful Disease Areas and Patient Populations for PDTs"

EP. 6 Identifying the Most Impactful Disease Areas and Patient Populations for PDTs

4 KOLs discuss PDTs

EP. 7 Evolving Commercialization and Distribution Models for PDTs

4 KOLs discuss PDTs

EP. 8 Promoting Appropriate PDT Prescribing Through Provider Education and Support

A panel of 4 experts on PDTs

EP. 9 Optimizing Provider Education, Utilization Monitoring, and Value-Based Contracts for PDTs

A panel of 4 experts on PDTs

EP. 10 Optimizing Benefit Design and Implementation for Improved PDT Access

A panel of 4 experts on PDTs

EP. 11 PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Helen Nde, MPH

Hepatitis B Re-Engagement Program Highlights Data, Access Gaps: Helen Nde, MPH

ByBrooke McCormick,Helen Nde, MPH,Laura Joszt, MA

August 24th 2026

A survey of physicians across 5 nations found varying degrees of suboptimal confidence in care delivery across MCL and CLL. | Image: AdobeStock.

A Multi-Country Needs Assessment on MCL and CLL Management

August 22nd 2026

Ochsner Medical Center exterior | Image: Ochsner

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

August 21st 2026

Complementary, Not Competing: How an Endocrinologist Compares Dual Incretin Approaches for Obesity and MASH

ByJaime Almandoz, MD, MBA

August 21st 2026

From Siloed to Synchronized: Building the Multidisciplinary Care Model That MASH Patients Need

ByJaime Almandoz, MD, MBA

August 21st 2026

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

Student Mental Health, Success Tied to Future Health and Affordability

FDA Approves First Orexin Agonist for Narcolepsy Type 1

A Multi-Country Needs Assessment on MCL and CLL Management